Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease dermatomyositis
Comorbidity C0206062|interstitial lung disease
Sentences 29
PubMedID- 25431723 At the initial visit, clinically amyopathic dermatomyositis (cadm) with rapidly progressive interstitial lung disease (rp-ild) was suspected because he had progressive dyspnea but no muscle weakness.
PubMedID- 22863719 Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases.
PubMedID- 20800454 Serum tarc/ccl17 levels are increased in dermatomyositis associated with interstitial lung disease.
PubMedID- 25622670 Objective: to explore the clinical features and prognosis of dermatomyositis patients with interstitial lung disease (ild) as an initial manifestation.
PubMedID- 25698373 A case of anti-mda5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
PubMedID- 20506189 Methods: we examined the medical records of all 16 dermatomyositis patients with interstitial lung disease seen in our outpatient university hospital dermatology clinic between may 26, 2006, and may 25, 2009.
PubMedID- 22460910 We report two cases of clinically amyopathic dermatomyositis (cadm) complicated by rapid progress interstitial lung disease (rpild).
PubMedID- 25433590 [interstitial lung disease-associated with amyopathic dermatomyositis and anti-mda5 autoantibodies].
PubMedID- 24325117 Objective: to investigate the clinical features and risk factors associated with interstitial lung disease (ild) in patients with classic dermatomyositis (classic dm) or clinical amyopathic dermatomyositis (cadm).
PubMedID- 23423441 This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease.
PubMedID- 22931947 [clinical characteristics of juvenile dermatomyositis complicated with interstitial lung disease].
PubMedID- 26459323 The objective of this study is to assess serum il8 and the potential activity of circulating neutrophils on relative messenger rna (mrna) levels and their relationship with disease activity in clinically amyopathic dermatomyositis (cadm) associated with interstitial lung disease (ild).
PubMedID- 23158422 Objective: to explore the possible diagnostic values of serum surfactant protein-a (sp-a) and surfactant protein-d (sp-d) for interstitial lung diseases (ild) in patients with polymyositis or dermatomyositis (pm/dm).
PubMedID- 21532064 Anti-cadm-140 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and cardiac involvement.
PubMedID- 24142786 [interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
PubMedID- 21285059 interstitial lung disease associated with polymyositis/dermatomyositis (ild-pm/dm) often confers a poor prognosis, and optimal treatment of this condition is not well defined.
PubMedID- 22325787 Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease.
PubMedID- 25346167 Anti-transcription intermediary factor 1-gamma antibody-positive clinically amyopathic dermatomyositis complicated by interstitial lung disease and breast cancer.
PubMedID- 23400027 Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia.
PubMedID- 23569020 Objective: : to study the clinical features of interstitial lung disease (ild) in patients with dermatomyositis and factors related to its development.
PubMedID- 26328651 Rapidly progressive interstitial lung disease associated with dermatomyositis treated with combination of immunosuppressive therapy, direct hemoperfusion with a polymyxin b immobilized fiber column and intravenous immunoglobulin.
PubMedID- 22781896 [a clinical analysis of dermatomyositis with interstitial lung disease in 20 patients].
PubMedID- 23908005 Objective: to assess the utility of anti-melanoma differentiation-associated gene 5 (anti-mda5) antibody measurement for predicting a risk for developing rapidly progressive interstitial lung disease (rp-ild) in patients with polymyositis/dermatomyositis (pm/dm).
PubMedID- 23257529 We herein report the clinical and laboratory characteristics of two anti-oj (anti-isoleucyl-trna synthetase) autoantibody-positive interstitial lung disease patients with polymyositis/dermatomyositis (pm/dm).
PubMedID- 26101728 Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
PubMedID- 25888887 Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.
PubMedID- 21748914 Subsequently, a diagnosis of amyopathic dermatomyositis with interstitial lung disease and pneumomediastinum was made.
PubMedID- 23250474 Autoantibodies against melanoma differentiation-associated gene 5 (mda5) are important serological markers in dermatomyositis (dm) with rapidly progressive interstitial lung disease (ild).
PubMedID- 24252021 Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease.

Page: 1